C4 Therapeutics, Inc. (CCCC) has a market capitalization of $228.6M and trades at $2.76. The 52-week range is 1.085-3.82.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.2, Earnings Per Share (EPS) of $-1.27, annual revenue of $35.95M.
The stock has a beta of 2.86, operates in the Healthcare sector.
